X-Chem, Pfizer Collaborate on Screening for Inflammatory, Orphan Diseases | GenomeWeb

NEW YORK (GenomeWeb) – Biotech firm X-Chem today announced a multi-target collaboration with Pfizer for the potential development of new treatments for inflammatory and orphan diseases.

X-Chem will apply its discovery engine to identify new leads for several of Pfizer's treatment development programs. Pfizer has an exclusive option to license compounds generated from the collaboration. Further details of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: CRISPR-based barcodes to trace cell lineages, and more.

The director of the National Institutes of Health Francis Collins sang the national anthem this week before a baseball game.

French researchers criticize unexpected government plan to cut research funding, ScienceInsider reports.

In Nature this week: genetic mechanism through which some cancers evade the immune system, and more.